Endo International PLC ENDP:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
7.65quote price arrow down-0.28 (-3.53%)
Volume
101,660
Close
7.93quote price arrow down-1.38 (-14.82%)
Volume
8,795,883
52 week range
2.08 - 10.89

...

Loading . . .

KEY STATS

  • Open8.75
  • Day High9.14
  • Day Low7.78
  • Prev Close9.31
  • 52 Week High10.89
  • 52 Week High Date02/18/21
  • 52 Week Low2.08
  • 52 Week Low Date03/18/20
  • Market Cap1.826B
  • Shares Out230.29M
  • 10 Day Average Volume3.49M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • 1 Year % Change40.85

RATIOS/PROFITABILITY

  • EPS (TTM)1.05
  • P/E (TTM)7.52
  • Fwd P/E (NTM)3.79
  • EBITDA (MRQ)1.279B
  • ROE (MRQ)-368.12%
  • Revenue (MRQ)2.908B
  • Gross Margin (MRQ)49.34%
  • Net Margin (MRQ)-3.52%
  • Debt To Equity (MRQ)-1,067.53%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Endo International PLC News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded...
Paul Campanelli
Chairman
Blaise Coleman
President
Terrance Coughlin
Chief Operating Officer
Domenico Ciarico
Executive Vice President
Patrick Barry
Executive Vice President
Address
Minerva House, Simmonscourt Road
Dublin
000 00
Ireland